{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:41:55Z","timestamp":1791636115164,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"HRSA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018156","name":"Sangamo Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"ONR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jtct.2023.03.024","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T02:12:19Z","timestamp":1679883139000},"page":"380.e1-380.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7828-1522","authenticated-orcid":false,"given":"Tristan E.","family":"Knight","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4567-8037","authenticated-orcid":false,"given":"Kwang Woo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle M.","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Atshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5442-5536","authenticated-orcid":false,"given":"Donna A.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanhatai","family":"Chiengthong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2896-1113","authenticated-orcid":false,"given":"Seth J.","family":"Rotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5548-0206","authenticated-orcid":false,"given":"Ellen","family":"Fraint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3371-2920","authenticated-orcid":false,"given":"Hemalatha G.","family":"Rangarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1515-2141","authenticated-orcid":false,"given":"Jeffery J.","family":"Auletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3281-2081","authenticated-orcid":false,"given":"Akshay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9216-2901","authenticated-orcid":false,"given":"Carrie L.","family":"Kitko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2804-2531","authenticated-orcid":false,"given":"Baldeep","family":"Wirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Dvorak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5528-4405","authenticated-orcid":false,"given":"Kasiani C.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3030-8420","authenticated-orcid":false,"given":"Michael A.","family":"Pulsipher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6247-1233","authenticated-orcid":false,"given":"Anne B.","family":"Warwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5651-7426","authenticated-orcid":false,"given":"Nahal Rose","family":"Lalefar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk R.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna","family":"Qayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1674-048X","authenticated-orcid":false,"given":"Larisa","family":"Broglie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Eapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Yanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.03.024_bib0001","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.bbmt.2017.04.018","article-title":"Hematopoietic stem cell transplantation activity in pediatric cancer between 2008 and 2014 in the United States: a Center for International Blood and Marrow Transplant Research Report","volume":"23","author":"Khandelwal","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.024_bib0002","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000120664","article-title":"Short- and long-term complications of radiation therapy for pediatric brain tumors","volume":"18","author":"Donahue","year":"1992","journal-title":"Pediatr Neurosurg"},{"key":"10.1016\/j.jtct.2023.03.024_bib0003","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/08880010390243031","article-title":"Second malignant neoplasms after primary central nervous system malignancies of childhood and adolescence","volume":"20","author":"Devarahally","year":"2003","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtct.2023.03.024_bib0004","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1200\/JCO.2001.19.8.2302","article-title":"Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis","volume":"19","author":"Palmer","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.03.024_bib0005","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/bmt.2016.45","article-title":"Decreased morbidity and mortality of autologous hematopoietic transplants for children with malignant central nervous system tumors: the \u201cHead Start\u201d trials, 1991\u20132009","volume":"51","author":"Altshuler","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.024_bib0006","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/1097-0142(19950215)75:4<1045::AID-CNCR2820750422>3.0.CO;2-K","article-title":"Survival of infants with malignant astrocytomas. A Report from the Children's Cancer Group","volume":"75","author":"Geyer","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2023.03.024_bib0007","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1200\/JCO.1994.12.8.1607","article-title":"Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Children's Cancer Group","volume":"12","author":"Geyer","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.03.024_bib0008","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1200\/JCO.2005.09.095","article-title":"Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group","volume":"23","author":"Geyer","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.03.024_bib0009","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1470-2045(05)70252-7","article-title":"Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children","volume":"6","author":"Grill","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtct.2023.03.024_bib0010","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199306173282401","article-title":"Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors","volume":"328","author":"Duffner","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.03.024_bib0011","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1200\/JCO.1996.14.9.2495","article-title":"Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group","volume":"14","author":"Finlay","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.03.024_bib0012","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/neuonc\/nop031","article-title":"High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma","volume":"12","author":"Dunkel","year":"2010","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.jtct.2023.03.024_bib0013","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/pbc.10369","article-title":"High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors","volume":"42","author":"Broniscer","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.03.024_bib0014","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00146088","article-title":"Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?","volume":"27","author":"Dupuis-Girod","year":"1996","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jtct.2023.03.024_bib0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1200\/JCO.1998.16.1.210","article-title":"Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors","volume":"16","author":"Mason","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.03.024_bib0016","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1200\/JCO.2004.12.126","article-title":"Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma","volume":"22","author":"Chi","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.03.024_bib0017","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/pbc.21307","volume":"50","author":"Fangusaro","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.03.024_bib0018","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/pbc.21525","article-title":"Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the \u201cHead Start\u201d I and II protocols","volume":"50","author":"Dhall","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.03.024_bib0019","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/pbc.21578","article-title":"Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors","volume":"51","author":"Gardner","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.03.024_bib0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/pbc.24648","article-title":"Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid\/rhabdoid tumors: the Head Start III experience","volume":"61","author":"Zaky","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.03.024_bib0021","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/neuonc\/noaa102","article-title":"Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on \u201cHead Start\u201d III: a multi-institutional, prospective clinical trial","volume":"22","author":"Dhall","year":"2020","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.jtct.2023.03.024_bib0022","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11060-013-1111-9","article-title":"Outcome of infants and young children with newly diagnosed ependymoma treated on the \u201cHead Start\u201d III prospective clinical trial","volume":"113","author":"Venkatramani","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jtct.2023.03.024_bib0023","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pediatrneurol.2015.03.019","article-title":"Pilot study of intensive chemotherapy with peripheral hematopoietic cell support for children less than 3 years of age with malignant brain tumors, the CCG-99703 Phase I\/II Study. A Report From the Children's Oncology Group","volume":"53","author":"Cohen","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jtct.2023.03.024_bib0024","unstructured":"Nationwide Children's Hospital. HeadStart4: newly diagnosed children (<10 y\/o) with medulloblastoma and other CNS embryonal tumors clinical and molecular risk-tailored intensive and compressed induction chemotherapy followed by consolidation with randomization to either single cycle or to three tandem cycles of marrow-ablative chemotherapy with autologous hematopoietic progenitor cell rescue. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02875314. Accessed May 20, 2021."},{"key":"10.1016\/j.jtct.2023.03.024_bib0025","unstructured":"Children's Oncology Group. A Phase III randomized trial for the treatment of newly diagnosed supratentorial PNET and high risk medulloblastoma in children <36 months old with intensive induction chemotherapy with methotrexate followed by consolidation with stem cell rescue versus the same therapy without methotrexate. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00336024. Accessed May 23, 2021."},{"issue":"4","key":"10.1016\/j.jtct.2023.03.024_bib0026","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1200\/JCO.1999.17.4.1227","article-title":"Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support","volume":"17","author":"Schulman","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.03.024_bib0027","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.bbmt.2018.01.032","article-title":"Low CD34(+) cell doses are associated with increased cost and worse outcome after tandem autologous stem cell transplantation in patients with relapsed or refractory germ cell tumors","volume":"24","author":"Hyder","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.024_bib0028","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40164-019-0131-3","article-title":"The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994\u20132016","volume":"8","author":"Carlsten","year":"2019","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.jtct.2023.03.024_bib0029","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1080\/10428194.2020.1762879","article-title":"Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study","volume":"61","author":"Turunen","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2023.03.024_bib0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jamainternmed.2021.4826","article-title":"Comparison of classification of indications for allogeneic and autologous transplant for adults in ASTCT Guidelines and evidence available in published literature","volume":"182","author":"Kim","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtct.2023.03.024_bib0031","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41409-018-0353-8","article-title":"Peripheral blood progenitor cell collection in pediatric patients optimized by high pre-apheresis count of circulating CD34+ cells and high blood flow","volume":"54","author":"Karow","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.024_bib0032","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0973-6247.164273","article-title":"Autologous peripheral blood stem cell harvest: Collection efficiency and factors affecting it","volume":"10","author":"Tiwari","year":"2016","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.jtct.2023.03.024_bib0033","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.transci.2008.04.011","article-title":"Allogeneic peripheral blood stem cell collection as of 2008","volume":"38","author":"Rhodes","year":"2008","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtct.2023.03.024_bib0034","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1537-2995.2012.03911.x","article-title":"A prospective study on the efficacy of mobilization of autologous peripheral stem cells in pediatric oncohematology patients","volume":"53","author":"Cesaro","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2023.03.024_bib0035","first-page":"85","article-title":"Large volume leukapheresis is efficient and safe even in small children up to 15 kg body weight","volume":"15","author":"Bojanic","year":"2017","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jtct.2023.03.024_bib0036","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1744-9987.2011.00990.x","article-title":"Mobilization and harvesting of peripheral blood stem cells in pediatric patients with solid tumors","volume":"15","author":"Veljkovic","year":"2011","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jtct.2023.03.024_bib0037","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bbmt.2008.02.002","article-title":"Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients","volume":"14","author":"Schmid","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.024_bib0038","first-page":"943","article-title":"Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation","volume":"18","author":"Ravoet","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.024_bib0039","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/bmt.2014.296","article-title":"Engraftment syndrome: double-edged sword of hematopoietic cell transplants","volume":"50","author":"Spitzer","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.024_bib0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fped.2019.00133","article-title":"Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management","volume":"7","author":"Dvorak","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jtct.2023.03.024_bib0041","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.bbmt.2010.02.008","article-title":"Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation","volume":"16","author":"Palomo","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.024_bib0042","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2011.65","article-title":"The role of the endothelium in the short-term complications of hematopoietic SCT","volume":"46","author":"Carreras","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.024_bib0043","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmpb.2007.07.010","article-title":"A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model","volume":"88","author":"Zhang","year":"2007","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.jtct.2023.03.024_bib0044","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmpb.2010.07.005","article-title":"SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models","volume":"101","author":"Zhang","year":"2011","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.jtct.2023.03.024_bib0045","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1080\/10428194.2016.1222378","article-title":"Relapse risk after autologous stem cell transplantation in patients with lymphoma based on CD34+ cell dose","volume":"58","author":"Sorigue","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2023.03.024_bib0046","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/scd.1.1992.1.329","article-title":"Defining a therapeutic dose of peripheral blood stem cells","volume":"1","author":"Bender","year":"1992","journal-title":"J Hematother"},{"key":"10.1016\/j.jtct.2023.03.024_bib0047","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2020.2565","article-title":"Presumed asymptomatic carrier transmission of COVID-19","volume":"323","author":"Bai","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2023.03.024_bib0048","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/trf.16198","article-title":"Mobilization characteristics, blood graft composition, and outcome in diffuse large B-cell lymphoma after autologous stem cell transplantation: Results from the prospective multicenter GOA study","volume":"61","author":"Partanen","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2023.03.024_bib0049","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.bbmt.2016.01.024","article-title":"Immunologic autograft engineering and survival in non-Hodgkin lymphoma","volume":"22","author":"Porrata","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.024_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.leukres.2019.03.009","article-title":"Autograft immune content and survival in non-Hodgkin's lymphoma: a post hoc analysis","volume":"81","author":"Porrata","year":"2019","journal-title":"Leuk Res"},{"key":"10.1016\/j.jtct.2023.03.024_bib0051","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40425-018-0491-y","article-title":"Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation","volume":"7","author":"Lee","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jtct.2023.03.024_bib0052","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/ITT.S198162","article-title":"Immunotherapy for medulloblastoma: current perspectives","volume":"9","author":"Kabir","year":"2020","journal-title":"Immunotargets Ther"},{"key":"10.1016\/j.jtct.2023.03.024_bib0053","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.3390\/cancers13215387","article-title":"Immunotherapy in medulloblastoma: current state of research, challenges, and future perspectives","volume":"13","author":"Voskamp","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jtct.2023.03.024_bib0054","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JOP.18.00767","article-title":"CNS tumors in adolescents and young adults: the need for a holistic specialized approach","volume":"16","author":"Papageorgiou","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.jtct.2023.03.024_bib0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.semradonc.2009.09.005","article-title":"Brain tumors across the age spectrum: biology, therapy, and late effects","volume":"20","author":"Merchant","year":"2010","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.jtct.2023.03.024_bib0056","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bbmt.2010.11.021","article-title":"Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma","volume":"17","author":"Stiff","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.024_bib0057","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1089\/scd.2004.13.598","article-title":"What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant?","volume":"13","author":"Jillella","year":"2004","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jtct.2023.03.024_bib0058","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.bmt.1705298","article-title":"Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation","volume":"37","author":"Pavone","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.024_bib0059","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbmt.2013.11.003","article-title":"Prediction of poor mobilization of autologous CD34+ cells with growth factor in multiple myeloma patients: implications for risk-stratification","volume":"20","author":"Costa","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl","key":"10.1016\/j.jtct.2023.03.024_bib0060","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.1016\/S2666-6367(22)00484-5","article-title":"Effect of autograft CD34\u00a0+\u00a0dose on outcome in pediatric patients undergoing autologous hematopoietic stem cell transplant for central nervous system tumors","volume":"28","author":"Knight","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"Suppl","key":"10.1016\/j.jtct.2023.03.024_bib0061","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.1016\/S2666-6367(22)00483-3","article-title":"Impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastomas","volume":"28","author":"Knight","year":"2022","journal-title":"Transplant Cell Ther"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723011995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723011995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:10:12Z","timestamp":1763003412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723011995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2666636723011995"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.03.024","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}